Edmond DE Rothschild Holding S.A. decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 52.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,688 shares of the company’s stock after selling 3,000 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in Colgate-Palmolive were worth $160,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. raised its holdings in Colgate-Palmolive by 13.5% during the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock worth $3,609,804,000 after buying an additional 7,236,342 shares during the period. Oregon Public Employees Retirement Fund raised its holdings in Colgate-Palmolive by 5,779.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,625,533 shares of the company’s stock worth $95,000 after buying an additional 5,529,852 shares during the period. Ceredex Value Advisors LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $71,576,000. Los Angeles Capital Management & Equity Research Inc. raised its holdings in Colgate-Palmolive by 405.4% during the 4th quarter. Los Angeles Capital Management & Equity Research Inc. now owns 1,283,928 shares of the company’s stock worth $76,419,000 after buying an additional 1,029,873 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its holdings in Colgate-Palmolive by 3.2% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock worth $1,935,674,000 after buying an additional 1,000,161 shares during the period. 75.02% of the stock is currently owned by institutional investors and hedge funds.

Several brokerages have commented on CL. Credit Suisse Group began coverage on shares of Colgate-Palmolive in a report on Wednesday, March 6th. They set an “underperform” rating on the stock. BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Jefferies Financial Group restated a “hold” rating and set a $61.00 target price on shares of Colgate-Palmolive in a report on Friday, February 1st. Wells Fargo & Co restated a “hold” rating and set a $57.00 target price on shares of Colgate-Palmolive in a report on Thursday, January 31st. Finally, Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 30th. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $65.13.

In related news, CTO Patricia Verduin sold 2,218 shares of the business’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.38, for a total transaction of $147,230.84. Following the transaction, the chief technology officer now directly owns 48,671 shares in the company, valued at $3,230,780.98. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Ian M. Cook sold 22,634 shares of the business’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now owns 1,162,793 shares in the company, valued at $77,104,803.83. The disclosure for this sale can be found here. Insiders sold 51,700 shares of company stock worth $3,419,284 over the last quarter. 1.02% of the stock is owned by corporate insiders.

NYSE CL opened at $67.20 on Monday. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $72.61. The company has a market capitalization of $57.90 billion, a PE ratio of 22.63, a price-to-earnings-growth ratio of 4.25 and a beta of 0.78.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company had revenue of $3.81 billion for the quarter, compared to the consensus estimate of $3.78 billion. During the same period last year, the company earned $0.75 earnings per share. The firm’s revenue was down 2.1% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.43 dividend. The ex-dividend date is Wednesday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.56%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.57%.

TRADEMARK VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2019/03/18/colgate-palmolive-cl-position-trimmed-by-edmond-de-rothschild-holding-s-a.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: What is a Leveraged Buyout (LBO)?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.